Equitec Proprietary Markets’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Equitec Proprietary Markets’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,800	Closed	-$940K	–	301
2022 Q3	$940K	Buy	+13,800	New	+$761K	0.25%	53

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Equitec Proprietary Markets's GBT Position: Q4 2022 in Review

Equitec Proprietary Markets sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 13,800 shares — an estimated $940K sold.

Equitec Proprietary Markets first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $940K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Equitec Proprietary Markets reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Equitec Proprietary Markets sold 13,800 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $940K.
Equitec Proprietary Markets first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Equitec Proprietary Markets's Global Blood Therapeutics, Inc. position peaked at $940K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Equitec Proprietary Markets's 13F filing for Q4 2022, filed 31 Jan 2023.